STING1 and cancer: In cancer cells, RT-induced endogenous production of IFN-I primarily relies on the cGAS/STING pathway activated by cytoplasmic dsDNA, boosting cancer immunogenicity and strengthening antitumor immune responses, leading to better treatment outcomes (90).